Related Experiment Video
Updated: May 11, 2026
12:17
Construction and Implantation of a Microinfusion System for Sustained Delivery of Neuroactive Agents.
Published on: March 17, 2008
Industry Update: the latest developments in therapeutic delivery.
1Philips Healthcare, Clinical Science & Research Programs, Philips Healthcare - Clinical Research Board, 3000 Minuteman Road, Andover, MA 01810, USA. oliver.steinbach@philips.com
Therapeutic Delivery
|May 8, 2013
Summary
The pharmaceutical industry faces challenges but shows recovery in drug delivery deals. Focus is shifting to patient compliance through altered oral delivery and alternative administration routes.
Area of Science:
- Pharmaceutical industry analysis
- Healthcare market trends
- Drug delivery innovations
Background:
- The US healthcare market faces challenges including fiscal policy and healthcare reform.
- The pharmaceutical industry suffers from low public perception.
- The drug delivery sector experienced a decline in deals in 2012 but shows signs of recovery.
Purpose of the Study:
- To provide an industry update on drug delivery partnering deals and trends.
- To highlight the shift towards patient compliance in drug delivery.
- To identify emerging trends in alternative drug administration routes.
Main Methods:
- Information sourced from company press releases, regulatory and patent agencies.
- Analysis of scientific literature.
- Review of recent licensing deals and financing rounds in the drug delivery sector.
Main Results:
- A slight recovery in drug delivery partnering deals was observed in 2012 after a decline.
- Increased emphasis on altered oral delivery profiles for patient compliance.
- Growing interest in alternative administration routes like nasal and sublingual, despite bioavailability challenges.
Conclusions:
- The pharmaceutical industry is expected to see a trend reversal in 2013 with companies refilling pipelines.
- Patient compliance is a key driver for innovation in oral drug delivery.
- While alternative administration routes are gaining traction, challenges in bioavailability and dosing remain.
Related Concept Videos
01:16Drug Delivery: Overview
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the gastrointestinal...
01:19Modified-Release Drug Delivery Systems: Overview
Modified-release dosage forms are designed to address the limitations of drugs with short biological half-lives. These forms maintain stable therapeutic drug concentrations over extended periods, reducing the need for frequent dosing. A consistent drug level helps minimize peak-trough fluctuations, which can reduce adverse effects, lower the risk of drug resistance, and improve overall treatment effectiveness.One common type of modified-release form is the extended-release (ER) formulation. ER...
01:24Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
01:22Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
01:27Drug Delivery Systems: Different Types
Conventional oral drug products, termed immediate-release (IR) formulations, are engineered to promptly release their active pharmaceutical ingredient (API) upon ingestion, typically in tablets or capsules. This rapid release often results in swift drug absorption and consequent pharmacodynamic effects, although the timing and intensity can vary depending on the drug's properties. Prodrugs within these formulations require metabolic conversion to activate their pharmacodynamic effects,...
01:20Modified-Release Drug Delivery Systems: Influencing Factors
Modified-release drug delivery systems are designed to optimize the therapeutic effect of drugs by minimizing side effects, reducing the dosage required, and controlling drug release to align with pharmacokinetic and pharmacodynamic needs. The system depends on two key factors: the drug's release from the formulation and its movement through the body to the target site. Unlike conventional dosage forms, where absorption is the limiting step, the rate of drug release is the key determinant in...